Tuesday 17 October 2017
Contact US    |    Archive
PR
25 days ago

Janssen Receives Complete Response Letter From U.S. FDA For Sirukumab Biologics License Application

HORSHAM, Pa., Sept. 22, 2017 /PRNewswire/ -- Janssen Biotech, Inc. (Janssen) announced today that it

Read on the original site


Hashtags:   

Janssen

 | 

Receives

 | 

Complete

 | 

Response

 | 

Letter

 | 

From

 | 

FDA

 | 

For

 | 

Sirukumab

 | 

Biologics

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries